Literature DB >> 4821444

Salicylamide metabolism in acute intermittent porphyria.

C S Song, H L Bonkowsky, D P Tschudy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4821444     DOI： 10.1002/cpt1974154431

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Antipyrine metabolism in acute hepatic porphyria in relapse and remission.

Authors:  G G Birnie; K E McColl; G G Thompson; M R Moore; A Goldberg; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

3.  Salycylamide glucuronide formation in liver disease and its change by drugs.

Authors:  Y Adachi; G Wakisaka; T Yamamoto
Journal:  Gastroenterol Jpn       Date:  1975

4.  Delta-Aminolaevulinic acid and amino acid neurotransmitters.

Authors:  M J Brennan; R C Cantrill
Journal:  Mol Cell Biochem       Date:  1981-08-11       Impact factor: 3.396

Review 5.  Influences of diet and nutrition on clinical pharmacokinetics.

Authors:  K E Anderson
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.